Search Result "ultra-high risk"


The Ultra High Risk Approach to Define Psychosis Risk

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 346-350
Author(s): Alison R. Yung, Paolo Fusar-Poli, Barnaby Nelson

Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 570-575
Author(s): Gregor E. Berger, Stephen J. Wood, Margaret Ross, Clare A. Hamer, R. Mark Wellard, Gaby Pell, Lisa Phillips, Barnaby Nelson, G. Paul Amminger, Alison R. Yung, Graeme Jackson, Dennis Velakoulis, Christos Pantelis, Husseini Manji, Patrick D McGorry

Reliability and Validity of the Comprehensive Assessment of the at Risk Mental State, Italian Version (CAARMS-I)

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 386-391
Author(s): P. Fusar-Poli, R. Hobson, M. Raduelli, U. Balottin

Review Article

Recent Advances in Lanthanide Based Nano-Architectures as Probes for Ultra High-Field Magnetic Resonance Imaging

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 3 Year: 2020 Page: 352-361
Author(s): Silvanose Biju,Tatjana N. Parac-Vogt

Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 566-569
Author(s): Marta Hauser, Georg Juckel

Glutamate and Psychosis Risk

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 466-478
Author(s): Alice Egerton, Paolo Fusar-Poli, James M. Stone

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 3 Year: 2012 Page: 5036-5044
Author(s): Floor J. van der Meer, Eva Velthorst, Carin J. Meijer, Marise W.J. Machielsen, Lieuwe de Haan

Research Article

Degradation Kinetics Study of Anastrozole in Different Conditions by Reverse-Phase High-Performance Liquid Chromatography and Confirmation of its Major Degradation Product by Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry

Journal: Current Pharmaceutical Analysis
Volume: 15 Issue: 3 Year: 2019 Page: 217-223
Author(s): Linjia Sun,Xiaoyang Sun,Yu Chen,Binjie Wang,Xiaohui Chen

Review Article

Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 5676-5686
Author(s): Giulia Bruzzone, Giorgia Corbelli, Paola Belci, Annalaura Cremonini, Aldo Pende, Livia Pisciotta

Recent Methods for Assessing Osteoporosis and Fracture Risk

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 48-59
Author(s): Kazuhiro Imai

Previous   Next

Go To   Results 1 - 1 of 2896

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy